Abstract
Background: Cancer is the main cause of morbidity and mortality worldwide, and its symptoms can affect an individual’s life holistically.
Objectives: Our study aimed to determine the health-related quality of life (HRQoL) of individuals dealing with cancer in the Free State, South Africa.
Method: A descriptive, cross-sectional study design utilising the standardised Functional Assessment of Cancer Therapy – General (FACT-G) questionnaire as well as a self-developed sociodemographic and general health information questionnaire was used in this study. The study was conducted at the Universitas Annex Oncology Clinic.
Results: A total of 507 participants were conveniently sampled. The median age was 53 years with 73.8% being female. The FACT-G’s overall score ranged from 11.7 to 108, with a median of 76.7 (interquartile range [IQR] 63–89.5). The Social or Family Well-Being subscale indicated the highest median of 22.2 and the Emotional Well-Being subscale the lowest of 18. The Physical Well-Being subscale found that 61.8% of individuals felt forced to spend time in bed and 53.4% experienced nausea. The Functional Well-Being subscale showed that 70.3% of individuals accepted their illness and 51.6% enjoyed their life.
Conclusion: Our study highlights the importance of using a clinical assessment tool to determine the influence of cancer on the individual’s HRQoL. Involvement of the individual’s family and friends during management, as well as identifying the need for psychosocial support, is crucial for positively influencing HRQoL.
Clinical implications: The FACT-G is a valuable tool in guiding physiotherapists and other healthcare professionals with patients’ cancer-related treatment experiences.
Keywords: FACT-G; HRQoL; cancer; physiotherapy; well-being.
Introduction
In Africa, approximately 2000 lives are lost daily because of cancer, which has become a notable public health challenge worldwide (Omotoso et al. 2023). Numerous factors, including ageing, unhealthy lifestyle choices and population growth, have contributed to the increased projection of 70% new cancer cases by 2030 (Jedy-Agba et al. 2020; Hamdi et al. 2021; World Health Organization [WHO] 2022). In South Africa, a person’s carcinogen exposure plays a big role in the development of cancer. This includes pesticides, industrial and consumer products and pollution. These factors cause unusual immune system responses, and a series of complications can arise that affect the patient’s health-related quality of life (HRQoL) and incur financial costs (Herbst 2017). Ageing is another major factor in cancer incidence and mortality, with most cases reported between 36 and 55 years (Hamdi et al. 2021). Despite the increasing mortality rate, cancer is not prioritised by stakeholders and policymakers in addressing the impact that the disease and its treatment has on individuals dealing with cancer, their families and communities (Hamdi et al. 2021).
Patient-centred HRQoL has become an important health outcome for clinical practice (Buiting & Olthuis 2020; De Boer et al. 2016; Zapatero et al. 2021; Zheng et al. 2021). Health-Related Quality of Life is defined as ‘how well a person functions in their life and his or her perceived well-being in physical, mental, and social domains of health’ (Karimi & Brazier 2016:646). Determining patients’ HRQoL and functional ability is essential for healthcare professionals to provide insight into patients’ emotional, physical, social or family and functional well-being (Buiting & Olthuis 2020). In addition, HRQoL identifies specific individual needs and perceptions that might influence treatment decisions facilitating person-centred care, focusing on survival and treatment-related experiences (Shahjalal et al. 2023). Determining HRQoL among individuals dealing with cancer throughout their treatment also aligns with the sustainable development goals (SDGs), particularly goal three, aimed at good health and well-being (Sustainable Development Goals 2024). Furthermore, understanding how HRQoL outcomes vary with sociodemographic and clinical factors may offer insight into clinical practice, health policy and individualised healthcare interventions (Shahjalal et al. 2023).
Cancer research is not limited to medical interventions as a form of treatment; it also extends to physiotherapy and the effects thereof on the HRQoL of patients (Sweegers et al. 2019). Although improvements in cancer treatment have led to a decline in death rates among cancer patients, these treatments are usually accompanied by side effects, which negatively affect the patient. Along with the side effects, treatment-related experiences can also impact the patient’s HRQoL long after therapy has concluded (CANSA 2022).
Two outcome measures are available to determine HRQoL of individuals dealing with cancer, the Functional Assessment of Cancer Therapy – General (FACT-G) questionnaire (FACT-G 2023) and the European Organisation for Research and Treatment of Cancer Quality-of-Life Questionnaire Core 30 (EORTC QLQ-C30) (Hand 2016; Luckett et al. 2011). Both these questionnaires have their merits; however, they cover different aspects of HRQoL despite also having a fair amount of overlap. A study conducted by Kemmler et al. (1999) indicated that neither of the two instruments can be replaced by the other, but the EORTC QLQ-C30 seemed to concentrate largely on the physical and functional aspects of quality of life, while the aim of our study was to include all the domains of an individual’s life. The FACT-G is commonly used in oncology research (Schurr et al. 2023) and several studies (Jabari, Nawajah & Jabareen 2022; Schurr et al. 2023) have used the FACT-G to study and determine the HRQoL in individuals dealing with cancer. Therefore, the FACT-G was chosen as measurement instrument for our study.
The FACT-G consists of four subscales, Social or Family Well-Being (SWB), Physical Well-Being (PWB), Functional Well-Being (FWB) and Emotional Well-Being (EWB). SWB refers to the entire family dynamics and functioning. This changes because of cancer, and the progression or recovery affects patients as well as their families and caregivers emotionally and psychologically. Understanding how psychosocial factors influence the entire course of cancer is becoming increasingly more important (Wang & Feng 2022). The PWB refers to the physical activities that are essential for the functional independence of a person (Schurr et al. 2023) and the ability to carry out activities and social tasks without physical limitations and bodily pain or fatigue (Capio, Cindy & Abernethy 2014). This is determined by self-reported symptoms, including a lack of energy, nausea, trouble with meeting the needs of the patient’s family, pain, side effects of the treatment, feeling ill and being forced to spend time in bed (Schurr et al. 2023). Functional Well-Being is a pivotal HRQoL indicator in individuals dealing with cancer and grades the capability of individuals to conduct basic tasks inside and outside their homes (Schurr et al. 2023). Sánchez, Ballesteros and Arnold (2011) describe EWB as a person’s ‘emotional state’, which includes individual’s emotional symptoms and how they cope with their illness.
Health-Related Quality of Life in individuals dealing with cancer influences the outcome of their treatment (Jansen van Rensburg, Maree & Casteleijn 2017) and impacts their functional independence (Schurr et al. 2023). Research on the HRQoL of individuals dealing with cancer has been conducted worldwide (Jabari et al. 2022; Schurr et al. 2023), as well as in a public hospital in Gauteng, South Africa (Jansen van Rensburg et al. 2017). The aim of our study was to determine the HRQoL of individuals dealing with cancer in the Free State, South Africa by using the FACT-G questionnaire.
Research methods and design
A descriptive cross-sectional study design utilising the standardised, self-administered FACT-G questionnaire as well as a self-developed questionnaire to gather sociodemographic and general health information was used. The FACT-G is a well validated and reliable questionnaire (Costet et al. 2005; Sánchez et al. 2011). Costet et al. (2005) indicated satisfactory internal consistency of the global FACT-G scale (Cronbach’s alpha α = 0.9) and subscales (α > 0.75). The highest possible score for the PWB, SWB and FWB is 28, and for the EBW, is 24 (Brucker et al. 2005). The four subscales of the FACT-G questionnaire are scored with a 5-point Likert-type scale. The FACT-G consists of 27 items that evaluate HRQoL and is aimed at individuals dealing with cancer from the age of 18 years and older, based on the individual’s life experiences during the past 7 days. The scores range from zero to four, where four is the highest and zero is the lowest possible score per individual question. There are seven questions per subscale with some items required to be reversed scored. A total FACT-G score is calculated by combining all the subscales’ scores. The lowest possible total FACT-G score is zero, and the maximum score is 108 (Brucker et al. 2005). No normative data exist for disease, symptom- or condition-specific subscales, but higher scores for the different scales and subscales indicate a higher HRQoL (Benjamin, Jason & Lauren 2021).
Our study population consisted of individuals dealing with cancer admitted to the oncology wards or attending the oncology clinic at Universitas Annex in Bloemfontein. The monthly admissions at Universitas Annex range between 1000 and 1200 patients. Convenience sampling was used, and the recommended sample size of 341 individuals was calculated using the Raosoft sample size calculator (Raosoft 2004). Participants were included if they were 18 years and older, provided informed consent, were diagnosed with any type of cancer and were literate in either Afrikaans, English or Sesotho. A pilot study, following the same procedure as the main study, was conducted after ethical approval was obtained. Recruitment and data collection took place from February to April of 2023.
The information document was provided to each participant in their language of choice. Participation in our study was voluntary and participants who provided informed consent were handed questionnaires to complete. Confidentiality of the participants was ensured by numbering the questionnaires. Researcher assistants were available to assist the participants throughout the process.
After completion of the questionnaires, the authors transferred the data to a password-protected Excel spreadsheet and hard copies of the questionnaires were stored in a lockable safe. Data analyses were performed by the Department of Biostatistics, University of the Free State (UFS). Descriptive statistics were calculated for both numerical and categorical data.
Ethical considerations
Ethical approval for our study was obtained from the Health Science Research Ethics Committee (HSREC) (UFS-HSD2022/1452/2911), Gatekeepers of the UFS and the Free State Department of Health. Participants were informed that they were allowed to withdraw from our study at any stage and that no risks were involved. Participants were informed that they would receive no remuneration to participate in our study, and if the study’s findings were to be published, it would be presented in group format and not participant specific. The study data were managed according to the Protection of Personal Information Act 4 of 2013 (POPIA).
Results
The total number of participants was 507, of whom 73.8% were female. The median age was 53 years. More than half (59.0%) who participated were human immunodeficiency virus (HIV) positive. Breast cancer (39.3%) was the most prevalent cancer, followed by cervical (16.96%) and prostate cancer (10.3%). It was noteworthy that 46.9% were unaware of the stage of their cancer and 63.5% were receiving chemotherapy during the time that our study was conducted. A summary of the main sociodemographic information of our study population can be viewed in Table 1.
TABLE 1: Summary of sociodemographic information (N = 507). |
The total score on the FACT-G questionnaire ranged from a minimum of 11.7 to a maximum of 108, with a median of 76.7. Median and interquartile range values are reported as the numerical data were not normally distributed. The highest median illustrated (refer to Table 2) was from the SWB subscale (22.2), whereas the lowest median was from the EWB subscale (18). However, the mean values were also calculated to allow for comparison to other studies.
TABLE 2: Summary of Functional Assessment of Cancer Therapy – General scale scores (N = 507). |
No association was found between age and the FACT-G total score (p = 0.3). When comparing the median total score of the FACT-G, individuals dealing with skin cancer experienced the lowest HRQoL (69) and those with brain cancer the highest (85). It is interesting to notice that 23 participants were unsure about which cancer they were dealing with (refer to Table 3).
TABLE 3: Functional Assessment of Cancer Therapy – General total scores for each type of cancer (N = 478). |
The subscale items for which more than 50% of participants indicated a ‘4’ (‘very much’) are highlighted in Table 4.
TABLE 4: Subscales of Functional Assessment of Cancer Therapy – General scale scores (N = 507). |
The PWB subscale (refer to Table 4) found that the most common complaint (61.8%) was that they were forced to spend time in bed and the most common symptom experienced was nausea (53.4%). The PWB can be devastating for individuals dealing with cancer; however, EWB can also have a large impact on HRQoL. Nearly two-thirds of the participants in our study (65.9%) stated that they were ‘losing hope in their fight against their illness’ and were ‘worried about dying’ (56.8%). Despite these sentiments, 50.2% still felt ‘satisfied with how they were coping with their illness’. While experiencing challenges with PWB and EWB, 70.3% felt they had accepted their illness and 51.6% could enjoy life. Most participants felt well supported by their families (69%) and satisfied with family communication (74%) and 78.9% indicated that their family members had accepted their illness.
Discussion
The sample of 507 participants was representative of the target population. The distribution of males versus females was 1:3, which was different from the approximately 1:1 distribution of females (51.3%) and males (48.6%) diagnosed with cancer in South Africa in 2018 (Stats SA 2023). The median age was 53 years, while the median age at diagnosis of cancer was 59 years for females and 64 years for males in 2018 (Stats SA 2023). The WHO (2022) determined that the most common types of cancer worldwide were breast, lung, colorectal, prostate and skin cancer, which is like our study but in contrast, cervical cancer was also prevalent.
The total FACT-G median score of a study conducted by Jeon et al. (2020) on individuals dealing with advanced non-small-cell lung cancer was 64. The aim of the study was to evaluate the prognostic value of HRQoL using the FACT-G. The total FACT-G median score was 76.7 in our study. This could be attributed to 47% of our participants not knowing what stage of cancer they have while the participants in Jeon et al. (2020) were all in the advanced stage. A similar study was conducted by Tchen et al. (2004) on patients dealing with breast cancer and found a total FACT-G median score of 77. The study of Tchen et al. (2004) matched their study participants with a healthy control group by age and the normative value for the HRQoL of the control group was 93. The study was conducted in Canada, which in 2023 was viewed as a high-income country while South Africa is an upper-middle income country (The World Bank 2024). No normative data for the HRQoL of the general population in South Africa utilising the FACT-G is available. The population of Tchen et al. (2004) only included breast cancer, which was also most prevalent in our study, although other types of cancers were also included. A study conducted by Chagani et al. (2017) in Pakistan (low-income country) assessed the HRQoL and its determinants in cancer patients undergoing chemotherapy. The mean for the overall HRQoL was 57.37, which was much lower than the overall HRQoL found in our study. It is interesting to notice that the SWB subscale score in the Chagani et al. (2017) was higher (22.3) than the score in our study (20.9), while all the other scores were lower. It is acknowledged that adverse effects are experienced during chemotherapy, which affects the HRQoL of individuals dealing with cancer and could thus explain the differences in findings (Chagani et al. 2017) as only 63.5% of the participants in our study were receiving chemotherapy.
The median value for the SWB in the study of Jeon et al. (2020) was 18.7 and in our study 22.2. Support from family, friends and partners positively influences HRQoL (Jabari et al. 2022) and effective coping strategies (Sari, Dewi & Dauley 2019) of individuals dealing with cancer. These results highlight the importance of support and are further substantiated by the findings of Jabari et al. (2022), indicating that this subscale showed the best scores on positively influencing an individual’s HRQoL. A qualitative exploratory study conducted in a hospital in Gauteng by Jansen van Rensburg et al. (2017) exploring the perception of individuals dealing with cancer found that the support from family, friends, their spouse and church members enhanced their HRQoL as the participants could share their experiences. Being separated from their family caused emotional distress as the participants were not only worried about their treatment but also their family. The philosophy of Ubuntu is promoted in African culture and is based on the concept that ‘a person is a person through other people’ (Taylor 2014) and includes ‘interdependency in terms of caring’ (Mabovula 2011) and sharing, which explains the negative experience of being separated from family and friends and the negative influence on HRQoL of individuals dealing with cancer. Social support is not only important in African cultures but also in other cultures.
The FWB of a patient directly impacts the quality of the patient’s emotional, physical and social well-being (Yeung et al. 2020). The median score of the FWB was 20 and in Jeon et al. (2020) 15. Almost three-quarters of participants felt that they had accepted their illness and just over half of the participants were happy with their lives. These results not only depict the positive influence FWB has on EWB, PWB and SWB and therefore on the HRQoL of the individual but also the influence of coping strategies as discussed earlier.
The median value for PWB in our study as well as in Jeon et al. (2020) was both 19. Most participants complained of nausea and that they were forced to spend time in bed. Pyszora et al. (2017) compared a group of individuals dealing with cancer in a palliative care department who participated in physiotherapy for 2 weeks, with a control group who received no physiotherapy. The therapy group reported a statistically significant reduction in their fatigue and drowsiness and rated their well-being higher than the control group. Eyigor (2010) found that individuals dealing with cancer who were bed-bound benefited from exercise. Individuals engaging in an exercise programme experienced an increase in their HRQoL, and cardiovascular capacity, as well as an improvement in their sleep and fatigue. Furthermore, a feeling of wellness developed, and their body mass index and immunity improved.
The median EBW subscale score was 18 and in Jeon et al. (2020) 15. In our study, half of the participants reported that they were coping well with their condition, but a larger percentage reported that they felt they were losing hope in their fight against their illness and were worried about dying. This corresponds with the research of Jabari et al. (2022) who found that participants also had the lowest scores for these items. Cancer is stressful and results in lifestyle changes. The process that takes place when an individual is dealing and coping with cancer is a unique experience and may be explained in terms of Lazarus and Folkman’s psychological stress model and the critical events model of Filipp, as cited in Homa, Ziarko and Litwiniuk (2023). According to these models, the source of stress and the consequences of the stress experiences arise not only from the physical aspects of the disease but also from past experiences, such as the patient’s assessment of the disease and their coping strategies. In the critical events model by Filipp, the concept of critical life events emphasises confronting stress by distinguishing the types of stresses, the so-called stressors of critical life events (CLEs). These stressors could be patients with no experience of a life-threatening disease or of their own experience or experience with a close family member. Hence, the differences in coping mechanisms and stress by individuals dealing with cancer will depend on their own or their family’s history of life-threatening disease (Homa et al. 2023).
Clinical implications
Health-Related Quality of Life remains a complex concept, which is impacted by various individual factors both positive and negative. Our study indicates how the supportive role of healthcare professionals involving family, friends and partners as support during cancer treatment-related experiences influences HRQoL positively. The multi-disciplinary care of individuals dealing with cancer should be coordinated to address and evolve to ensure that the individual receives adequate and appropriate support to deal with the stress of the life-threatening disease and to maintain HRQoL despite the disease and the treatment-related experiences. Referral of individuals dealing with cancer to the appropriate healthcare professionals is essential to ensure the holistic well-being of the individual and their family. All other subscales of the FACT-G can also be positively addressed by physiotherapy interventions, which could be delivered individually or in group settings to improve the HRQoL of individuals dealing with cancer.
Limitations
Patients were sampled from a single hospital at Universitas Annex in Bloemfontein. As such, the results may not be nationally representative, but the hospital is the referral hospital not only for the Free State but also for the Northern Cape and Lesotho. Participants who were unable to read, write or understand Afrikaans, English or Sesotho were excluded from our study, and because of urbanisation, there are also individuals dealing with cancer who are speaking other languages indigenous to the Free State.
Recommendations
Similar studies should be conducted in other provinces in South Africa using the FACT-G questionnaire so that the results can be compared throughout the provinces and be more representative of the country. More specific HRQoL should be determined for each type of cancer as different challenges are experience depending on the type and stage of cancer that the individual is dealing with. These questionnaires are freely available online. Multiple linear regression analysis should be performed in future to explain the variability in the HRQoL, which would contribute to determining factors associated with HRQoL of individuals dealing with cancer.
Conclusion
As one of the first studies determining the HRQoL of individuals dealing with cancer in the Free State using the FACT-G questionnaire, numerous findings deserve special attention. The findings demonstrated that the participants had the poorest results under the EWB subscale. Despite EWB being scored out of 24 rather than 28, these results still emphasise the need for improvements in psychosocial interventions to decrease the number of individuals experiencing challenges with EWB while dealing with cancer and treatment-related experiences. Therefore, it is crucial for physiotherapists to not only identify individuals with affected EWB but also to refer these individuals to other healthcare professionals. The results of the SWB indicated that HRQoL was positively influenced by SWB, highlighting the importance of a support structure. Functional Well-Being and PWB are crucial components of HRQoL in individuals dealing with cancer, and physiotherapists can play a valuable role in assisting with increasing the HRQoL of individuals dealing with cancer by providing exercise interventions, health education, support and referral where needed.
Acknowledgements
The researchers would like to extend their gratitude to the staff and patients of the Oncology ward and clinic at the National District Hospital, Universitas Annex in Bloemfontein, Free State. The researchers would further like to acknowledge the final year physiotherapy students of 2023 for data collection and Mrs Jané Welman for assistance with data capturing.
Competing interests
The authors declare that they have no financial or personal relationships that may have inappropriately influenced them in writing this article.
Authors’ contributions
K.B. and R.Y.B. conducted the literature search and writing of the article. R.Y.B. was responsible for capturing the data. M.N. was responsible for data analysis and input in the final article.
Funding information
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.
Data availability
The data that support the findings of this study are available from the corresponding author, R.Y.B. upon reasonable request.
Disclaimer
The views and opinions expressed in this article are those of the authors and are the product of professional research. The article does not necessarily reflect the official policy or position of any affiliated institution, funder, agency or that of the publisher. The authors are responsible for this article’s results, findings and content.
References
Benjamin, A., Jason, B. & Lauren, L., 2021, Functional Assessment of Cancer Therapy – General, viewed April 2024, from https://www.facit.org/measures/FACT-G.
Brucker, P.S., Yost, K., Cashy, J., Webster, K. & Cella, D., 2005, ‘General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G)’, Evaluation & the Health Professions 28(2), 192–211. https://doi.org/10.1177/0163278705275341
Buiting, H.M. & Olthuis, G., 2020, ‘Importance of quality-of-life measurement throughout the disease course’, JAMA Network Open 3(3), e200388. https://doi.org/10.1001/jamanetworkopen.2020.0388
CANSA, 2022, CANSA on cancer myths, viewed July 2022, from https://cansa.org.za/cansa-on-cancer-myths/.
Capio, C.M., Cindy, H.S. & Abernethy, B., 2014, ‘Physical well-being’, in A.C. Michalos (ed.), Encyclopedia of quality of life and well-being research, pp. 4805–4807, SpringerReference, s.l.
Chagani, P., Parpio, Y., Gul, R. & Jabbar, A.A., 2017, ‘Quality of life and its determinants in adult cancer patients undergoing chemotherapy treatment in Pakista’, Asia-Pacific Journal of Oncology Nursing 4(2), 140–166. https://doi.org/10.4103/2347-5625.204499
Costet, N., Lapierre, V., Benhamou, E. & Le Galès, C., 2005, ‘Reliability and validity of the Functional Assessment of Cancer Therapy (FACT-G) in French patients living with cancer’, Quality of Life Research 14, 1427–1432. https://doi.org/10.1007/s11136-004-5531-z
De Boer, S.M., Powell, M.E., Mileshkin, L., Katsaros, D., Bessette, P. & Haie-Meder, C., 2016, ‘Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): An open-label, multicentre, randomised, phase 3 trial’, The Lancet Oncology 17(8), 1114–1126. https://doi.org/10.1016/S1470-2045(16)30120-6
Eyigor, S., 2010, ‘Physical activity and rehabilitation programs should be recommended on palliative care for patients with cancer’, Journal of Palliative Medicine 13(10), 1. https://doi.org/10.1089/jpm.2010.0064
Fact-G, FACIT Group, 2023, viewed 25 August 2023, from https://www.facit.org/measures/FACT-G#:~:text=The%20Functional%20Assessment%20of%20Cancer,cancer%20and%2015%20oncology%20specialists.
Hamdi, Y., Abdeljaoued-Tej, I., Zatchi, A.A, Abdelhak, S., Boubaker, S. & Brown, J.S., 2021, ‘Cancer in Africa: The untold story’, Frontiers in Oncology 15(11), 650117. https://doi.org/10.3389/fonc.2021.650117
Hand, C., 2016, ‘Measuring health-related quality of life in adults with chronic conditions in primary care settings: Critical review of concepts and 3 tools’, Canadian Family Physician 62(7), 375–383, viewed July 2022, from https://www.cfp.ca/content/cfp/62/7/e375.full.pdf.
Herbst, M.C., 2017, Cancer Association of South Africa (CANSA): Fact sheet on cancer, viewed March 2022, from https://cansa.org.za/files/2017/05/Fact-Sheet-Cancer-May-2017-1.pdf.
Homa, M., Ziarko, M. & Litwiniuk, M., 2023, ‘Coping with cancer and a history of health-related events’, Reports of Practical Oncology and Radiotherapy 28(1), 66–73. https://doi.org/10.5603/RPOR.a2023.0012
Jabari, C.E., Nawajah, I. & Jabareen, H., 2022, ‘Fact-G assessment of the quality of life for Palestinian patients with cancer’, Qatar Medical Journal 2022(3), 43. https://doi.org/10.5339/qmj.2022.43
Jansen van Rensburg, J.J.M., Maree, J.E. & Casteleijn, D., 2017, ‘An investigation into the quality of life of cancer patients in South Africa’, Asia-Pacific Journal of Oncology Nursing 4(4), 336–341. https://doi.org/10.4103/apjon.apjon_41_17
Jedy-Agba, E., Joko, W.Y., Liu, B., Buziba, N.G., Borok, M., Korir, A. et al., 2020, ‘Trends in cervical cancer incidence in sub-Saharan Africa’, British Journal of Cancer 123(1), 148–154. https://doi.org/10.1038/s41416-020-0831-9
Jeon, H., Eo, W., Shim, B., Kin, S. & Lee, S., 2020, ‘Prognostic value of Functional Assessment of Cancer Therapy-General (FACT-G) in advanced non-small-cell lung cancer treated with Korean Medicine’, Hindawi Evidence-Based Complementary and Alternative Medicine 2020, 2845401. https://doi.org/10.1155/2020/2845401
Karimi, M. & Brazier, J., 2016, ‘Health, health-related quality of life, and quality of life: What is the difference?’, PharmacoEconomics 34, 645–649. https://doi.org/10.1007/s40273-016-0389-9
Kemmler, G., Holzner, B., Kopp, M., Dünser, M., Margreiter, R., Greil, R. et al., 1999, ‘Comparison of two quality-of-life instruments for cancer patients: The functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30’, Journal of Clinical Oncology 17(9), 2932–2940. https://doi.org/10.1200/JCO.1999.17.9.2932
Luckett, T., King, M.T., Butow, P., Oguchi, M., Rankin, N., Price, M.A. et al., 2011, ‘Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: Issues, evidence and recommendations’, Annals of Oncology 22, 2179–2190. https://doi.org/10.1093/annonc/mdq721
Mabovula, N.N., 2011, ‘The erosion of African communal values: A reappraisal of the African ubuntu philosophy’, Inkanyiso: Journal of Humanities and Social Sciences 3(1), 38–47. https://doi.org/10.4314/ijhss.v3i1.69506
Omotoso, O., Teibo, J.O., Atiba, F.A., Oladimeji, T., Paimo, O.K., Ataya, F.S. et al., 2023, ‘Addressing cancer care inequities in sub-Saharan Africa: Current challenges and proposed solutions’, Int J Equity Health 22(1), 189. https://doi.org/10.1186/s12939-023-01962-y
Pyszora, A., Budzyński, J., Wójcik, A., Prokop, A. & Krajnik, M., 2017, ‘Physiotherapy programme reduces fatigue in patients with advanced cancer receiving palliative care: Randomized controlled trial’, Supportive Care in Cancer 25(9), 2899–2908. https://doi.org/10.1007/s00520-017-3742-4
Raosoft, 2004, Sample size calculator, viewed May 2022, from https://www.raosoft.com/samplesize.html.
Sánchez, R., Ballesteros, M. & Arnold, B.J., 2011, ‘Validation of the FACT-G scale for evaluating quality of life in patients living with cancer in Colombia’, Quality of Life Research 20, 19–29. https://doi.org/10.1007/s11136-010-9727-0
Sari, D.K., Dewi, R. & Dauley, W., 2019, ‘Association between family support, coping strategies and anxiety in cancer patients Undergoing chemotherapy at general hospital in Medan, North Sumatera, Indonesia’, Asian Pacific Journal of Cancer Prevention 20, 3015–3019. https://doi.org/10.31557/APJCP.2019.20.10.3015
Schurr, T., Loth, F., Lidington, E., Piccinin, C., Arraras, J.I., Groenvold, M. et al., 2023, ‘Patient-reported outcome measures for physical function in cancer patients: Content comparison of the EORTC CAT Core, EORTC QLQ-C30, SF-36, FACT-G, and PROMIS measures using the International Classification of Functioning, Disability and Health’, BMC Medical Research Methodology 23, 21. https://doi.org/10.1186/s12874-022-01826-z
Shahjalal, M., Sultana, M., Gow, J., Hoque, M.E., Mistry, S.K., Hossain, A. et al., 2023, ‘Assessing health-related quality of life among cancer survivors during systemic and radiation therapy in Bangladesh: A cancer-specific exploration’, BMC Cancer 23, 1208. https://doi.org/10.1186/s12885-023-11670-z
Stats SA, 2023, Cancer report – A look at the latest findings, viewed 05 April 2024, from https://www.statssa.gov.za/?p=16217.
Sustainable Development Goals, 2024, United Nations South Africa, viewed 03 April 2024, from https://southafrica.un.org/en/sdgs.
Sweegers, M.G., Buffart, L.M., Van Veldhuizen, W.M., Geleun, E., Verheul, H.M.W., Brug, J. et al., 2019, ‘How does a supervised exercise program improve quality of life in patients with cancer? A concept mapping study examining patients’ perspectives’, The Oncologist 24(6), 374–383. https://doi.org/10.1634/theoncologist.2017-0613
Taylor, D.F., 2014, ‘Defining ubuntu for business ethics – A deontological approach’, South African Journal of Philosophy 33(3), 331–45. https://doi.org/10.1080/02580136.2014.948328
Tchen, N., Juffs, H., Downie, F., Li, O., Hu, H., Chemerynsky, I. et al., 2004, ‘Cognitive function, fatigue and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer’, The Women’s Oncology Review 4(2), 123–124, viewed from https://ascopubs.org/doi/10.1200/JCO.2003.01.119.
The World Bank, 2024, The world by income and region, viewed from https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html.
World Health Organization (WHO), 2022, viewed 25 August 2023, https://www.who.int/health-topics/cancer#tab=_1.
Wang, Y. & Feng, W., 2022, ‘Cancer-related psychosocial challenges’, General Psychiatry 35(5), e100871. https://doi.org/10.1136/gpsych-2022-100871
Yeung, N.C., Wang, L., Ji, L., Lu, Q. & Lu, G., 2020, ‘Difficulties in identifying and describing feelings, social constraints, affect, and functional well-being among Chinese breast cancer patients: A mediation model’, European Journal of Oncology Nursing 47, 101760. https://doi.org/10.1016/j.ejon.2020.101760
Zapatero, A., Pijoan, X.M., Gómez-Caamaño, A., Masferrer, J.P., Hernández, V.M., Morón, A.H. et al., 2021, ‘Health-related quality of life in men with localized prostate cancer treated with radiotherapy: Validation of an abbreviated version of the expanded prostate cancer index composite for clinical practice in Spain’, Health and Quality of Life Outcomes 19, 4–6. https://doi.org/10.1186/s12955-021-01856-z
Zheng, S., He, A., Yu, Y., Jiang, L., Liang, J. & Wang, P., 2021, ‘Research trends and hotspots of health-related quality of life: A bibliometric analysis from 2000 to 2019’, Health and Quality of Life Outcomes 19(1), 130. https://doi.org/10.1186/s12955-021-01767-z
|